ClinicalTrials.gg
Drug

Heparin, Low-Molecular-Weight clinical trials

A group of medicines. Enoxaparin (187 studies), Dalteparin (52 studies), Tinzaparin (37 studies) and others are counted on their own pages; this page counts the studies that name Heparin, Low-Molecular-Weight itself.

studies test it
57
open now
7
in phase 3
19
first study started
1999

How each study uses Heparin, Low-Molecular-Weight is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Heparin, Low-Molecular-Weight studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Low molecular weight heparin
20
LMWH
10
Enoxaparin
6
Heparin, Low-Molecular-Weight
4
Dalteparine
3

Medicines filed under Heparin, Low-Molecular-Weight

As reviewed, so not every one. Each counts its studies on its own page, not here.

Studies by the year they started

57 studies that test it; most in 2017 (6)

Studies that test Heparin, Low-Molecular-Weight, by start year
YearStudies
19991
20001
20021
20031
20052
20063
20081
20092
20105
20112
20122
20134
20151
20163
20176
20183
20191
20206
20214
20221
20232
20241
20252
20262

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
3
Phase 2
6
Phase 3
19
Phase 4
16
No phase
16

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 2 · Other 55

Mount Sinai Hospital, Canada (3) · Ain Shams University (3) · University Medical Center Groningen (2) · Azidus Brasil (2) · Suzanne C. Cannegieter, MD PhD (2) · Azienda Ospedaliera Universitaria Policlinico (2) · Shahid Beheshti University of Medical Sciences (2) · Huashan Hospital (1)

Often tested with

Tested in the same studies.

Aspirin (4) · Heparin (4) · Fluorouracil (3) · Tocilizumab (3) · Rivaroxaban (1) · Acetazolamide (1) · Argatroban (1) · Folic Acid (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 2 phase 3 studies under way

Heparin, Low-Molecular-Weight is the comparator. A study of two new drugs counts under both.

  • 2Aspirin · McMaster University, University of Calgary · next primary completion Jul 2027
  • 1Rivaroxaban · McMaster University · next primary completion Jul 2027
Reaching primary completion within a year · 1

Studies that test Heparin, Low-Molecular-Weight.

Studies

Open first, then newest update. How each study uses Heparin, Low-Molecular-Weight is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 57

See all 57 studies that test Heparin, Low-Molecular-Weight →

Given beside what is tested · 13 — Heparin, Low-Molecular-Weight is usual care or a partner of the new treatment
As the comparator · 15 — what is tested is compared with Heparin, Low-Molecular-Weight

Codes

What other systems call Heparin, Low-Molecular-Weight · ClinicalTrials.gg INT007604

  • MeSH (NLM) D006495Heparin, Low-Molecular-WeightOne source ClinicalTrials.gov

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.